Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Viruses ; 13(11)2021 10 28.
Artículo en Inglés | MEDLINE | ID: mdl-34834977

RESUMEN

Yersinia enterocolitica is a food-borne Gram-negative pathogen responsible for several gastrointestinal disorders. Host-specific lytic bacteriophages have been increasingly used recently as an alternative or complementary treatment to combat bacterial infections, especially when antibiotics fail. Here, we describe the proteogenomic characterization and host receptor identification of the siphovirus vB_YenS_ϕR2-01 (in short, ϕR2-01) that infects strains of several Yersinia enterocolitica serotypes. The ϕR2-01 genome contains 154 predicted genes, 117 of which encode products that are homologous to those of Escherichia bacteriophage T5. The ϕR2-01 and T5 genomes are largely syntenic, with the major differences residing in areas encoding hypothetical ϕR2-01 proteins. Label-free mass-spectrometry-based proteomics confirmed the expression of 90 of the ϕR2-01 genes, with 88 of these being either phage particle structural or phage-particle-associated proteins. In vitro transposon-based host mutagenesis and ϕR2-01 adsorption experiments identified the outer membrane vitamin B12 receptor BtuB as the host receptor. This study provides a proteogenomic characterization of a T5-type bacteriophage and identifies specific Y. enterocolitica strains sensitive to infection with possible future applications of ϕR2-01 as a food biocontrol or phage therapy agent.


Asunto(s)
Proteínas de la Membrana Bacteriana Externa/metabolismo , Proteínas Bacterianas/metabolismo , Proteínas de Transporte de Membrana/metabolismo , Siphoviridae/fisiología , Yersinia/virología , Bacteriófagos/clasificación , Bacteriófagos/genética , Bacteriófagos/aislamiento & purificación , Bacteriófagos/fisiología , Genoma Viral , Proteómica , Siphoviridae/clasificación , Siphoviridae/genética , Siphoviridae/aislamiento & purificación , Yersinia/genética , Yersinia enterocolitica/virología
2.
PLoS One ; 12(10): e0183950, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29016611

RESUMEN

The key of success of extraintestinal pathogenic Escherichia coli (ExPEC) to colonize niches outside the intestinal tract and to establish infection is the coordinated action of numerous virulence and fitness factors. The so-called high-pathogenicity island (HPI), responsible for synthesis, secretion and uptake of the siderophore yersiniabactin, proved to be an important virulence determinant. In this study we investigated the interaction of the flagellum-mediated motility and the HPI. The impairment of yersiniabactin production by deletion of irp2 or ybtA affected significantly motility. The gain of yersiniabactin production improved motility in both pathogenic and non-pathogenic E. coli strains. The loss of flagella expression had no adverse effect on the HPI. Strikingly, external iron abundance was not able to suppress activation of the HPI during motility. The HPI activity of swarming bacteria was comparable to iron deplete conditions, and could even be maximized by supplementing excessive iron. This fact is the first description of a regulatory mechanism, which does not follow the known hierarchical regulation of siderophore systems. Transcriptional reporter fusions of the ybtA promoter demonstrated that the entire promoter region with all YbtA binding sites is necessary for complete induction in both HPI-positive and HPI-negative strains. Altogether, these results suggest that the HPI is part of a complex regulatory network, which orchestrates various virulence mechanisms to optimize the overall fitness of ExPEC.


Asunto(s)
Movimiento Celular/genética , Escherichia coli Patógena Extraintestinal/genética , Flagelos/genética , Islas Genómicas/genética , Proteínas Bacterianas/genética , Escherichia coli Patógena Extraintestinal/patogenicidad , Proteína 2 Reguladora de Hierro/genética , Fenoles/metabolismo , Regiones Promotoras Genéticas , Tiazoles/metabolismo , Transactivadores/genética , Yersinia/genética , Yersinia/patogenicidad
3.
Appl Microbiol Biotechnol ; 100(1): 227-42, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26403922

RESUMEN

Bacterial phytases have attracted industrial interest as animal feed supplement due to their high activity and sufficient thermostability (required for feed pelleting). We devised an approach named KeySIDE,  an iterative Key-residues interrogation of the wild type with Substitutions Identified in Directed Evolution for improving Yersinia mollaretii phytase (Ymphytase) thermostability by combining key beneficial substitutions and elucidating their individual roles. Directed evolution yielded in a discovery of nine positions in Ymphytase and combined iteratively to identify key positions. The "best" combination (M6: T77K, Q154H, G187S, and K289Q) resulted in significantly improved thermal resistance; the residual activity improved from 35 % (wild type) to 89 % (M6) at 58 °C and 20-min incubation. Melting temperature increased by 3 °C in M6 without a loss of specific activity. Molecular dynamics simulation studies revealed reduced flexibility in the loops located next to helices (B, F, and K) which possess substitutions (Helix-B: T77K, Helix-F: G187S, and Helix-K: K289E/Q). Reduced flexibility in the loops might be caused by strengthened hydrogen bonding network (e.g., G187S and K289E/K289Q) and a salt bridge (T77K). Our results demonstrate a promising approach to design phytases in food research, and we hope that the KeySIDE might become an attractive approach for understanding of structure-function relationships of enzymes.


Asunto(s)
6-Fitasa/genética , 6-Fitasa/metabolismo , Evolución Molecular Dirigida/métodos , Ingeniería de Proteínas/métodos , Yersinia/enzimología , Yersinia/genética , 6-Fitasa/química , Sustitución de Aminoácidos , Estabilidad de Enzimas , Simulación de Dinámica Molecular , Temperatura
4.
Dtsch Med Wochenschr ; 127(37): 1893-6, 2002 Sep 13.
Artículo en Alemán | MEDLINE | ID: mdl-12226789

Asunto(s)
Antibacterianos/uso terapéutico , Artritis Reactiva/diagnóstico , Artritis Reactiva/tratamiento farmacológico , Animales , Antibacterianos/administración & dosificación , Antiinfecciosos/administración & dosificación , Antiinfecciosos/uso terapéutico , Anticuerpos Antibacterianos/análisis , Artritis Reactiva/etiología , Artritis Reactiva/microbiología , Azitromicina/administración & dosificación , Azitromicina/uso terapéutico , Infecciones por Chlamydia/diagnóstico , Chlamydia trachomatis/genética , Chlamydia trachomatis/inmunología , Chlamydia trachomatis/aislamiento & purificación , Ciprofloxacina/administración & dosificación , Ciprofloxacina/uso terapéutico , Ensayos Clínicos como Asunto , ADN Bacteriano/análisis , Diagnóstico Diferencial , Quimioterapia Combinada/uso terapéutico , Enteritis/diagnóstico , Enteritis/tratamiento farmacológico , Enteritis/etiología , Femenino , Humanos , Masculino , Modelos Teóricos , Reacción en Cadena de la Polimerasa , Rifampin/administración & dosificación , Rifampin/uso terapéutico , Salmonella/genética , Salmonella/inmunología , Salmonella/aislamiento & purificación , Infecciones por Salmonella/diagnóstico , Sensibilidad y Especificidad , Tetraciclinas/administración & dosificación , Tetraciclinas/uso terapéutico , Factores de Tiempo , Uretritis/diagnóstico , Uretritis/tratamiento farmacológico , Uretritis/etiología , Cervicitis Uterina/diagnóstico , Cervicitis Uterina/tratamiento farmacológico , Cervicitis Uterina/etiología , Yersinia/genética , Yersinia/inmunología , Yersinia/aislamiento & purificación , Yersiniosis/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA